气管支气管 Amyloidosis 导致左肺衰竭:一个病例报告
Rayhan Karimi1, Arun Adlakha2, Rob Thomas3
1Internal Medicine, Edward Via College of Osteopathic Medicine, Spartanburg, USA.
Cureus
|November 18, 2024
概括
气管支气管粉样性粉症是一种罕见的肺部疾病,涉及到空气道中粉样蛋白质的积累,导致呼吸问题. 诊断是具有挑战性的,但像支气管镜检查和全身疗法等治疗方法可以改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
背景情况:
- 气管支气管粉样性粉症是一种罕见的疾病,粉样蛋白沉积在呼吸道.
- 它呈现出模仿其他肺部疾病的呼吸道症状,使诊断复杂化.
关键词:
粉样蛋白质质量质量粉样蛋白质斑块是如何形成的氨基粉症是什么?支气管镜检查 (bronchoscopy) 是一种用来检查支气管.慢性支气管炎是一种慢性支气管炎.刚果红色污点 刚果红色污点肺部缩 肺部缩 肺部缩气管支气管支气管的更多相关视频
相关概念视频
Pneumothorax-I
170
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
170
Pneumothorax-II
120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
120
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K


